Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.
about
Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?Novel approaches to diagnosis and treatment of Juvenile Myelomonocytic Leukemia.A drug development perspective on targeting tumor-associated myeloid cells.Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
P2860
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.
@en
type
label
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.
@en
prefLabel
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms.
@en
P2093
P2860
P50
P356
P1476
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms
@en
P2093
Alberto Zambelli
Alessandro Rambaldi
Andrea Biondi
Anna Gallì
Carlos M Galmarini
Elisa Bonetti
Eugenio Erba
Franco Locatelli
Ilaria Craparotta
Laura Mannarino
P2860
P2888
P304
P356
10.1038/BJC.2016.424
P407
P577
2017-01-10T00:00:00Z
P6179
1033101741